cheshtasharma

About Cheshta Sharma

This author has not yet filled in any details.
So far Cheshta Sharma has created 1323 blog entries.

UK government’s announcement to ratify UPC

At a meeting of the EU’s Competitiveness Council, 28 November, the UK’s Intellectual Property Minister Lady Neville-Rolfe announced that the UK Government intends to ratify the Agreement on a Unified Patent Court. Its significance: As the UK (along with France and Germany) is one of the three countries whose ratification of the treaty is [...]

By |2017-09-08T13:34:36+05:30December 28th, 2016|Events, International, Patent|0 Comments

UCB sues MedImmune for Patent Infringement

Biopharmaceutical company UCB Biopharma (Union Chimique Belge is a multinational biopharmaceutical company headquartered in Brussels, Belgium) has filed a complaint against biotech developer MedImmune (MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007) for alleged patent infringement. The case, which was filed in the US District Court for [...]

By |2017-09-08T13:35:14+05:30December 28th, 2016|Patent, USA|0 Comments

Have you heard of Anti-trust law?

Many consumers have never heard of anti-trust laws, but enforcement of these laws saves consumers millions and even billions of dollars a year. Anti-trust laws - also referred to as "competition laws" - are statutes developed by the U.S. Government to protect consumers from predatory business practices by ensuring that fair competition exists in [...]

By |2017-09-08T13:36:26+05:30December 28th, 2016|Patent, USA|0 Comments

Nokia sues Apple: Patent infringement

An international patent dispute has broken out between Apple and Nokia over the Finnish mobile network vendor’s licensing terms for the widely used H.264 video codec and other technologies (like related to displays, user interface, software, antennae, chip sets). Nokia on Wednesday filed lawsuits against Apple in Germany and in the U.S., alleging that the [...]

By |2017-09-08T13:37:07+05:30December 28th, 2016|International, Patent|0 Comments

FDA Approves Olmesartan Generics

As readers with even very little attachment to lawsuits on intersection of patent and FDA law would know that this drug product had been a subject of herculean tug o’ war between generic rivals- Mylan (Mylan N.V. is an American global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices [...]

By |2017-09-08T13:39:14+05:30December 23rd, 2016|Patent|0 Comments
Go to Top